Tyrosine kinase inhibitor as adjuvant treatment of renal cell carcinoma: 1 versus 3

被引：0
|
作者：
Penel, Nicolas [1 ]
机构：
[1] Ctr Oscar Lambret, Dept Cancerol Gen, 3 Rue F Combemale, F-59020 Lille, France
来源：
BULLETIN DU CANCER | 2017年 / 104卷 / 09期
关键词：
Renal cell carcinoma; Adjuvant; Pazopanib; NEPHRECTOMY;
D O I：
10.1016/j.bulcan.2017.06.015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：705 / 706
页数：2
相关论文
共 50 条
  • [31] Adjuvant Treatment in Renal Cell Carcinoma
    Dizman, Nazli
    Adashek, Jacob J.
    Hsu, JoAnn
    Bergerot, Paulo G.
    Bergerot, Cristiane D.
    Pal, Sumanta K.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (08) : 555 - 563
  • [32] Adjuvant treatment for renal cell carcinoma
    Lam, JS
    Belldegrun, AS
    Figlin, RA
    EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (06) : 705 - 720
  • [33] Tyrosine Kinase Inhibitor Sunitinib Targets the Vasculature of Clear Cell Renal Cell Carcinoma: A Histological and Immunocytochemical Study of Treatment Effect
    Huang, J.
    Thomas, A.
    Simmerman, K.
    Sercia, L.
    Magi-Galluzzi, C.
    Campbell, S.
    Rini, B.
    Zhou, M.
    MODERN PATHOLOGY, 2010, 23 : 197A - 197A
  • [34] Tyrosine Kinase Inhibitor Sunitinib Targets the Vasculature of Clear Cell Renal Cell Carcinoma: A Histological and Immunocytochemical Study of Treatment Effect
    Huang, J.
    Thomas, A.
    Simmerman, K.
    Sercia, L.
    Magi-Galluzzi, C.
    Campbell, S.
    Rini, B.
    Zhou, M.
    LABORATORY INVESTIGATION, 2010, 90 : 197A - 197A
  • [35] Advanced Renal Cell Carcinoma: Tyrosine Kinase Inhibitors Versus Immune Checkpoint Inhibitors
    Rini, Brian I.
    ONCOLOGY-NEW YORK, 2022, 36 (08): : 511 - 515
  • [36] Tyrosine Kinase Inhibitors in Advanced Renal Cell Carcinoma: The Evolving Treatment Paradigm
    Bukowski, Ronald M.
    CLINICAL GENITOURINARY CANCER, 2009, 7 (01) : 9 - 10
  • [37] The role of tyrosine kinase inhibitors in the treatment of renal cell carcinoma with brain metastases
    Aytekin, Aydin
    Ciltas, Aydin
    Sahinli, Hayriye
    Benekli, Mustafa
    JOURNAL OF BUON, 2016, 21 (01): : 281 - 282
  • [38] Tyrosine Kinase Inhibitors in the Treatment of Advanced Renal Cell Carcinoma: Focus on Pazopanib
    Vasudev, Naveen S.
    Larkin, James M. G.
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2011, 5 : 333 - 342
  • [39] Focused Ultrasound-Triggered Release of Tyrosine Kinase Inhibitor From Thermosensitive Liposomes for Treatment of Renal Cell Carcinoma
    Abshire, Caleb
    Murad, Hakm Y.
    Arora, Jaspreet S.
    Liu, James
    Mandava, Sree Harsha
    John, Vijay T.
    Khismatullin, Damir B.
    Lee, Benjamin R.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 106 (05) : 1355 - 1362
  • [40] Tyrosine-kinase inhibitor sorafenib (S) in treatment of metastatic renal cell carcinoma cancer (mRCC) with lung metastases
    Popova, Irina L.
    Vladimirova, Liubov Yu
    Abramova, Natalya A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345